New drug shows promise in slowing deadly lung scarring
NCT ID NCT05621252
Summary
This study tested whether a new drug called PLN-74809 could reduce the buildup of scar tissue in the lungs of people with idiopathic pulmonary fibrosis (IPF). Ten participants took either the drug or a placebo pill daily for 12 weeks. Researchers used special PET/MRI scans to measure changes in lung scarring before and after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.